Přejít k obsahu
Merck

Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro.

Science advances (2022-12-10)
Ruchi Yadav, Valentine V Courouble, Sanjay K Dey, Jerry Joe E K Harrison, Jennifer Timm, Jesse B Hopkins, Ryan L Slack, Stefan G Sarafianos, Francesc X Ruiz, Patrick R Griffin, Eddy Arnold
ANOTACE

SARS-CoV-2, a human coronavirus, is the causative agent of the COVID-19 pandemic. Its genome is translated into two large polyproteins subsequently cleaved by viral papain-like protease and main protease (Mpro). Polyprotein processing is essential yet incompletely understood. We studied Mpro-mediated processing of the nsp7-11 polyprotein, whose mature products include cofactors of the viral replicase, and identified the order of cleavages. Integrative modeling based on mass spectrometry (including hydrogen-deuterium exchange and cross-linking) and x-ray scattering yielded a nsp7-11 structural ensemble, demonstrating shared secondary structural elements with individual nsps. The pattern of cross-links and HDX footprint of the C145A Mpro and nsp7-11 complex demonstrate preferential binding of the enzyme active site to the polyprotein junction sites and additional transient contacts to help orient the enzyme on its substrate for cleavage. Last, proteolysis assays were used to characterize the effect of inhibitors/binders on Mpro processing/inhibition using the nsp7-11 polyprotein as substrate.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
CD86 human, recombinant, expressed in E. coli, 0.5 mg protein/mL